“Test smarter, run faster.” That was the motto of Siemens Healthcare Diagnostics (Tarrytown, N.Y.) at the American Association for Clinical Chemistry and American Society for Clinical Laboratory Science 2013 Annual Meeting and Clinical Lab Expo, held July 28-Aug. 1 in Houston. DTTR sat down with CEO Michael Reitermann to get his view of the marketplace, the company’s latest platform, and how smarts and speed square with emerging technologies. What macro trends are you observing in the diagnostics industry? On a global scale, among the inherent growth drivers for our business are demographics and the aging population. From our perspective, these will continue to create a favorable climate for our industry. Then there are different trends when we look at the United States. There is huge pressure on the health care system, and one of the manifestations of that is the pressure on reimbursement. How do you see the implementation of the Affordable Care Act affecting the diagnostics space? I associate the [Affordable] Care Act with moving from a pay-per-procedure to a pay-per-insured-life perspective—or population-based insurance—and that has certain impacts on our industry. I believe that, hopefully, it will be a positive impact, because now diagnostic testing and early detection is […]